Study guide
8.1 Perinatal Transport and Maternal Complications
Certified Flight Paramedic FP-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Safety and Transport
1.1 Pre-Flight Operations and Equipment Stowing 1.2 Scene Safety and Landing Zone Management 1.3 In-Flight Emergency Response and Abort Protocols 1.4 Post-Incident Survival and Rescue Operations
2 Chapter 2: Flight Physiology
2.1 Gas Laws in Transport Medicine 2.2 Hypoxia: Classification and Corrective Actions 2.3 Environmental Stressors of Flight and Cabin Pressurization
3 Chapter 3: Airway, Anesthesia, and Analgesics
3.1 Advanced Airway Assessment and Difficult Airway Algorithms 3.2 Rapid Sequence Intubation (RSI) and Medication Selection 3.3 Mechanical Ventilation: Modes, Settings, and Monitoring 3.4 Transport Oxygen Systems and Duration Calculations 3.5 Anaesthetics and Induction Agents 3.6 Neuromuscular Blocking Agents 3.7 Analgesics and Vasoactive Sedative Titration
4 Chapter 4: Medical Emergencies
4.1 Respiratory Failure Pathologies (ARDS, Asthma, COPD) 4.2 Sepsis and Septic Shock Management 4.3 Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) 4.4 Toxicological Emergencies and Overdose Antidotes 4.5 Environmental Emergencies: Core Temperature Control (Hypo/Hyperthermia) 4.6 Adrenal Crisis and Incretin/Endocrine Emergencies
5 Chapter 5: Neurological Emergencies
5.1 Neurological Assessment and GCS Motor Scales 5.2 Traumatic Brain Injury (TBI) and Intracranial Pressure (ICP) Management 5.3 Stroke Care: Hemorrhagic vs. Ischemic Thrombectomy Candidates 5.4 Status Epilepticus Seizure Protocols 5.5 Spinal Trauma and Spinal Cord Syndromes
6 Chapter 6: Cardiac Emergencies
6.1 Acute Coronary Syndrome (ACS) and 12-Lead Interpretation 6.2 Dysrhythmias: Bradycardias and High-Grade AV Blocks 6.3 Cardiogenic Shock and Systemic Vascular Resistance (SVR) 6.4 Vasoactive Medication Titration (Norepinephrine, Epinephrine, Dopamine) 6.5 Mechanical Circulatory Support (IABP and ECMO Transport) 6.6 Post-Cardiac Arrest Care and Targeted Temperature Management
7 Chapter 7: Trauma/Burn Resuscitation
7.1 Damage Control Resuscitation and the Lethal Triad 7.2 Hemorrhage Control and Massive Transfusion Protocols (MTP) 7.3 Penetrating Thoracic Trauma and Cardiac Tamponade (Beck's Triad) 7.4 Blunt Force Deceleration Injuries (Traumatic Aortic Rupture) 7.5 Burn Physiology: Calculations (Parkland Formula) and Escharotomy
8 Chapter 8: Maternal, Fetal, and Neonatal Emergencies
8.1 Perinatal Transport and Maternal Complications 8.2 Ob/Gyn Emergencies and Emergency Delivery 8.3 Neonatal Resuscitation Program (NRP) Standards
9 Chapter 9: Pediatric Emergencies
9.1 Pediatric Assessment Triangle and Pathophysiology 9.2 Pediatric Airway and Ventilatory Management 9.3 Pediatric Pharmacology and Dosing Calculations 9.4 Pediatric Trauma and Resuscitation
10 Chapter 10: Professional Considerations
10.1 CAMTS Standards and Quality Metrics 10.2 Medical Ethics and Transport Law (EMTALA) 10.3 Crew Resource Management (CRM) and Human Factors
8.1 Perinatal Transport and Maternal Complications
Key Takeaways Explain This Topic AI
Always position the pregnant patient (>20 weeks gestation) in a left lateral tilt of 15-30 degrees or displace the uterus manually to the left to prevent aortocaval compression and maintain venous return.
Severe preeclampsia is diagnosed by blood pressure >= 160/110 mmHg on two occasions, or the presence of end-organ dysfunction such as thrombocytopenia (<100,000/uL), renal insufficiency (creatinine >1.1 mg/dL), or pulmonary edema.
Magnesium sulfate is the primary anticonvulsant for preeclampsia/eclampsia, administered as a 4-6 g IV loading dose followed by a 1-2 g/hr infusion. Monitor for toxicity by checking deep tendon reflexes, respiratory rate, and urine output.
Calcium gluconate (1 g of 10% solution IV over 5-10 minutes) is the first-line antidote for magnesium sulfate toxicity when respiratory depression or loss of DTRs occurs.
First-line antihypertensives in pregnancy include Labetalol (20-80 mg IV pushes, max 300 mg) and Hydralazine (5-10 mg IV slow push), targeting a gradual reduction to a diastolic pressure of 90-100 mmHg to preserve placental perfusion.
Last updated: July 2026
Perinatal Transport and Maternal Complications
Transporting a pregnant patient presents unique physiological challenges for the critical care transport team. The transport environment introduces stressors such as vibration, turbulence, and altitude-induced hypoxia, which can exacerbate maternal pathology and compromise fetal oxygenation. The flight paramedic must manage the maternal-fetal unit as two distinct but interdependent patients, prioritizing maternal stabilization as the primary means of safeguarding the fetus.
- Physiological Considerations and Perinatal Transport Logistics
- Aortocaval Compression and Patient Positioning
Beginning around 20 weeks of gestation, the gravid uterus is large enough to compress the inferior vena cava (IVC) and descending aorta against the spine when the patient is in the supine position. This phenomenon, known as aortocaval compression syndrome or supine hypotensive syndrome , can reduce venous return (preload) to the maternal heart by up to 30-40%, leading to a sudden drop in cardiac output, maternal hypotension, and immediate fetal hypoperfusion.
During transport, the patient should never be placed completely supine. Instead, the transport team must secure the patient with a left lateral tilt of 15 to 30 degrees using a wedge, rolled blankets under the right hip, or by tilting the entire stretcher if the transport vehicle allows. If lateral tilt is impossible due to spinal precautions or equipment limitations, manual left uterine displacement (LUD) must be performed continuously.
Loading diagram... Aortocaval Compression Syndrome
High-Altitude Physiology and Fetal Oxygenation
As cabin altitude increases during flight, the barometric pressure drops, leading to a decrease in the partial pressure of alveolar oxygen (PAO2) in accordance with Dalton's Law. Although a healthy mother can compensate for mild hypoxia, the fetus exists in a relatively hypoxic environment (fetal PaO2 is normally 25-30 mmHg) and relies on the high affinity of fetal hemoglobin (HbF) and a steep oxygen dissociation curve to maintain tissue oxygenation. Any maternal hypoxia (SpO2 < 95%) rapidly translates to severe fetal hypoxia. High-flow supplemental oxygen should be administered to the mother if there are signs of maternal respiratory distress, fetal distress, or if cabin altitude exceeds 5,000 feet.
Hypertensive Disorders of Pregnancy
Hypertensive disorders complicate approximately 10% of all pregnancies and remain a leading cause of maternal and neonatal morbidity. The flight paramedic must distinguish between gestational hypertension, preeclampsia, and preeclampsia with severe features, as their management pathways differ significantly.
Condition Diagnostic Criteria Clinical Findings
Gestational Hypertension SBP >= 140 mmHg or DBP >= 90 mmHg after 20 weeks gestation. No proteinuria; no systemic signs of end-organ damage.
Preeclampsia SBP >= 140 mmHg or DBP >= 90 mmHg after 20 weeks gestation. Proteinuria (>= 300 mg/24h or protein-to-creatinine ratio >= 0.3).
Preeclampsia with Severe Features SBP >= 160 mmHg or DBP >= 110 mmHg on two readings, OR hypertensive patient with end-organ dysfunction. Thrombocytopenia (<100,000/uL), creatinine >1.1 mg/dL, elevated LFTs (2x normal), pulmonary edema, cerebral/visual disturbances (headache, scotomata).
Eclampsia New-onset generalized tonic-clonic seizures in a patient with preeclampsia. Active or recent generalized seizures; risk of maternal intracranial hemorrhage.
HELLP Syndrome
HELLP syndrome is a severe manifestation of preeclampsia characterized by:
H emolysis: Microangiopathic hemolytic anemia (schistocytes on peripheral smear, elevated bilirubin >1.2 mg/dL, LDH >600 U/L).
E levated L iver enzymes: ALT or AST at least twice the upper limit of normal.
L ow P latelets: Thrombocytopenia with platelet count <100,000/uL.
These patients are at extreme risk for hepatic rupture, disseminated intravascular coagulation (DIC), and abruptio placentae. Transport must be initiated immediately to a tertiary care facility with neonatal intensive care (NICU) and maternal-fetal medicine (MFM) capabilities.
- Pharmacological Management of Preeclampsia and Eclampsia
- Magnesium Sulfate (MgSO4) Therapy
Magnesium sulfate is the gold standard for seizure prophylaxis in preeclampsia with severe features and is the primary treatment for eclamptic seizures. It is a central nervous system depressant and neuromuscular blocker that acts by competing with calcium ions, decreasing acetylcholine release at the neuromuscular junction, and producing cerebral vasodilation.
Loading Dose: 4 to 6 g IV diluted in 100 mL of Normal Saline or D5W, infused over 15 to 20 minutes.
Maintenance Dose: 1 to 2 g/hour continuous IV infusion via an infusion pump.
Eclamptic Seizure Recurrence: If a seizure occurs during the maintenance infusion, a one-time additional bolus of 2 g IV can be administered over 5-10 minutes.
Monitoring for Magnesium Toxicity
Because magnesium is excreted solely by the kidneys, patients with renal impairment (creatinine >1.1 mg/dL) are at high risk for toxicity. The flight paramedic must perform serial assessments of the following clinical indicators:
Deep Tendon Reflexes (DTRs): The patellar reflex is the first clinical sign to disappear, occurring at serum magnesium levels of 8-10 mEq/L .
Respiratory Rate: Respiratory depression occurs at levels of 12-15 mEq/L .
Cardiac Status: Conduction blocks and cardiac arrest occur at levels >20 mEq/L .
Urine Output: Must monitor hourly; urine output <30 mL/hour leads to rapid accumulation of magnesium.
Important
If DTRs are absent, respiratory rate falls below 12 breaths/min, or SpO2 decreases, stop the magnesium infusion immediately and prepare to administer the antidote.
Antidote for Magnesium Toxicity
Calcium Gluconate: Administer 1 g of 10% solution IV/IO over 5 to 10 minutes. Calcium gluconate is preferred in transport environments because it is less irritating to peripheral veins than calcium chloride.
Calcium Chloride: Alternatively, 1 g of 10% solution can be used if calcium gluconate is unavailable, but it should ideally be administered through a central line or large, patent peripheral line due to the risk of extravasation and tissue necrosis.
Antihypertensive Therapy in Hypertensive Crises
Antihypertensive therapy is indicated when blood pressure is sustained at SBP >= 160 mmHg or DBP >= 110 mmHg to prevent maternal hemorrhagic stroke. The goal is not to normalize blood pressure, but to lower it to a safe range ( SBP 140-150 mmHg and DBP 90-100 mmHg ). Rapidly reducing the blood pressure can result in severe placental hypoperfusion and acute fetal distress.
Labetalol (Beta-Blocker): First-line agent. Administer 20 mg IV push over 2 minutes. If ineffective, double the dose to 40 mg , then 80 mg every 10 minutes (maximum total dose of 300 mg ). Alternatively, initiate a continuous infusion of 1 to 2 mg/minute . Contraindicated in patients with asthma, bradycardia, or heart failure.
Hydralazine (Direct Vasodilator): Administer 5 to 10 mg IV slow push over 2 minutes. Repeat every 20 minutes as needed (maximum dose of 20 mg ). May cause maternal tachycardia and headache.
Nifedipine (Calcium Channel Blocker): If IV access is delayed, administer 10 to 20 mg orally (immediate release), repeat in 20 minutes if needed. Do not administer sublingually due to the risk of precipitous hypotension.